Back to Companies
Zentalis Pharmaceuticals, Inc.
ZNTLNasdaqCIK: 0001725160
Zentalis Pharmaceuticals, Inc. (ZNTL) shows 20 recent insider filings from 12 insiders, with 1 buying and 4 selling. With $7.8M in purchases and $10.1M in sales, the recent tape is a roughly balanced mix of buying and selling (net sales of $2.4M). Matrix Capital Management Company, LP (10% Owner) is the most active by dollar volume, and the single largest transaction was $10.0M by Matrix Capital Management Company, LP. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$22.3M
Purchases
$7.8M
Sales
$10.1M
Unique Insiders
12
Recent Insider Trades
20 loaded
| Jun 18 | ZNTL Zentalis Pharmaceuticals, Inc. | Walker Luke Nathaniel | Director | Grant | $0 |
| Jun 18 | ZNTL Zentalis Pharmaceuticals, Inc. | Johnson David Michael | Director | Grant | $0 |
| Jun 18 | ZNTL Zentalis Pharmaceuticals, Inc. | Kariuki Enoch | Director | Grant | $0 |
| Jun 18 | ZNTL Zentalis Pharmaceuticals, Inc. | Myers Scott Dunseth | Director | Grant | $0 |
| Jun 18 | ZNTL Zentalis Pharmaceuticals, Inc. | Skvarka Jan | Director | Grant | $0 |
| May 27 | ZNTL Zentalis Pharmaceuticals, Inc. | Campbell Shannon | Director | Grant | $0 |
| May 27 | ZNTL Zentalis Pharmaceuticals, Inc. | Campbell Shannon | Director | Other | $0 |
| Feb 10 | ZNTL Zentalis Pharmaceuticals, Inc. | Vultaggio Vincent | PAO and PFO | Sell | $97.6K |
| Feb 10 | ZNTL Zentalis Pharmaceuticals, Inc. | Bruns Ingmar | Chief Medical Officer | Sell | $8.0K |
| Feb 10 | ZNTL Zentalis Pharmaceuticals, Inc. | EASTLAND JULIA MARIE | CEO & President, Director | Sell | $21.2K |
| Feb 4 | ZNTL Zentalis Pharmaceuticals, Inc. | Vultaggio Vincent | PAO and PFO | Sell | $7.9K |
| Jan 9 | ZNTL Zentalis Pharmaceuticals, Inc. | Bruns Ingmar | Chief Medical Officer | Award | $1.0M |
| Jan 9 | ZNTL Zentalis Pharmaceuticals, Inc. | EASTLAND JULIA MARIE | CEO & President, Director | Award | $2.2M |
| Jan 9 | ZNTL Zentalis Pharmaceuticals, Inc. | Bucher James B | Chief Legal Officer | Award | $284.0K |
| Jan 9 | ZNTL Zentalis Pharmaceuticals, Inc. | Vultaggio Vincent | PAO and PFO | Award | $284.0K |
| Jan 8 | ZNTL Zentalis Pharmaceuticals, Inc. | WALTERS GROUP | 10% Owner | Buy | $7.8M |
| Jan 8 | ZNTL Zentalis Pharmaceuticals, Inc. | WALTERS GROUP | 10% Owner | Other | $0 |
| Dec 15 | ZNTL Zentalis Pharmaceuticals, Inc. | Matrix Capital Management Company, LP | 10% Owner | Sell | $10.0M |
| Oct 1 | ZNTL Zentalis Pharmaceuticals, Inc. | Bucher James B | Chief Legal Officer | Award | $616.0K |
| Sep 22 | ZNTL Zentalis Pharmaceuticals, Inc. | Bucher James B | Chief Legal Officer | Other | $0 |
20 filings